Novartis AG (NVS) Q3 2022 Earnings Results

Novartis Beats on EPS, Stock Up 1.03%

This earnings report shows that Novartis managed to exceed expectations on EPS, which likely contributed to the positive stock reaction. Investors may view this as a sign of resilience despite the absence of revenue data. The stock's increase of 1.03% reflects a generally favorable sentiment towards the company's performance and future prospects.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.58	N/A	+0.64%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They acknowledged challenges but remained focused on long-term growth.

Management highlighted strong performance in key therapeutic areas.

They emphasized ongoing commitment to innovation and pipeline development.

Novartis Beats on EPS, Stock Up 1.03%

Key numbers

Management commentary

Novartis AG

More earnings this week

Novartis Beats on EPS, Stock Up 1.03%

Key numbers

Management commentary